Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q347613> ?p ?o }
Showing triples 1 to 82 of
82
with 100 triples per page.
- Q347613 subject Q22230916.
- Q347613 subject Q6870315.
- Q347613 subject Q7145095.
- Q347613 subject Q7145142.
- Q347613 subject Q7215001.
- Q347613 subject Q7570636.
- Q347613 subject Q8824860.
- Q347613 abstract "Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a cyclooxygenase-2 selective inhibitor.Valdecoxib was manufactured and marketed under the brand name Bextra by G. D. Searle & Company as an anti-inflammatory arthritis drug. It was approved by the United States Food and Drug Administration on November 20, 2001, to treat arthritis and menstrual cramps. and was available by prescription in tablet form until 2005 when the FDA requested that Pfizer withdraw Bextra from the American market. The FDA cited "potential increased risk for serious cardiovascular (CV) adverse events," an "increased risk of serious skin reactions" and the "fact that Bextra has not been shown to offer any unique advantages over the other available NSAIDs."In September 2009 Bextra was at the center of the "largest health care fraud settlement and the largest criminal fine of any kind ever." Pfizer paid a $2.3 billion civil and criminal fine. Pharmacia and Upjohn, a Pfizer subsidiary, violated the United States Food, Drug and Cosmetic Act for misbranding Bextra "with the intent to defraud or mislead."A water-soluble and injectable prodrug of valdecoxib, parecoxib is marketed in the European Union under the tradename Dynastat.".
- Q347613 atcPrefix "M01".
- Q347613 atcSuffix "AH03".
- Q347613 bioavailability "83.0".
- Q347613 casNumber "181695-72-7".
- Q347613 chEBI "63634".
- Q347613 drugbank "DB00580".
- Q347613 fdaUniiCode "2919279Q3W".
- Q347613 iupacName "4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide".
- Q347613 pubchem "119607".
- Q347613 thumbnail Valdecoxib.svg?width=300.
- Q347613 wikiPageExternalLink www.cox2drugreview.org.
- Q347613 wikiPageExternalLink valdecoxibHCP.htm.
- Q347613 wikiPageWikiLink Q1053948.
- Q347613 wikiPageWikiLink Q1163923.
- Q347613 wikiPageWikiLink Q119697.
- Q347613 wikiPageWikiLink Q12152.
- Q347613 wikiPageWikiLink Q12171.
- Q347613 wikiPageWikiLink Q12202.
- Q347613 wikiPageWikiLink Q1470970.
- Q347613 wikiPageWikiLink Q14864419.
- Q347613 wikiPageWikiLink Q14916181.
- Q347613 wikiPageWikiLink Q1553390.
- Q347613 wikiPageWikiLink Q16.
- Q347613 wikiPageWikiLink Q180762.
- Q347613 wikiPageWikiLink Q18209480.
- Q347613 wikiPageWikiLink Q187255.
- Q347613 wikiPageWikiLink Q188724.
- Q347613 wikiPageWikiLink Q198605.
- Q347613 wikiPageWikiLink Q204711.
- Q347613 wikiPageWikiLink Q2123051.
- Q347613 wikiPageWikiLink Q22230916.
- Q347613 wikiPageWikiLink Q247489.
- Q347613 wikiPageWikiLink Q269829.
- Q347613 wikiPageWikiLink Q30.
- Q347613 wikiPageWikiLink Q3064815.
- Q347613 wikiPageWikiLink Q3067874.
- Q347613 wikiPageWikiLink Q329525.
- Q347613 wikiPageWikiLink Q347941.
- Q347613 wikiPageWikiLink Q377458.
- Q347613 wikiPageWikiLink Q411412.
- Q347613 wikiPageWikiLink Q458.
- Q347613 wikiPageWikiLink Q464880.
- Q347613 wikiPageWikiLink Q48.
- Q347613 wikiPageWikiLink Q5281998.
- Q347613 wikiPageWikiLink Q603741.
- Q347613 wikiPageWikiLink Q62736.
- Q347613 wikiPageWikiLink Q658255.
- Q347613 wikiPageWikiLink Q6870315.
- Q347613 wikiPageWikiLink Q7145095.
- Q347613 wikiPageWikiLink Q7145142.
- Q347613 wikiPageWikiLink Q7215001.
- Q347613 wikiPageWikiLink Q7570636.
- Q347613 wikiPageWikiLink Q816422.
- Q347613 wikiPageWikiLink Q81938.
- Q347613 wikiPageWikiLink Q8824860.
- Q347613 wikiPageWikiLink Q9368.
- Q347613 wikiPageWikiLink Q9377.
- Q347613 atcPrefix "M01".
- Q347613 atcSuffix "AH03".
- Q347613 bioavailability "83.0".
- Q347613 casNumber "181695".
- Q347613 chebi "63634".
- Q347613 drugbank "DB00580".
- Q347613 iupacName "4".
- Q347613 pubchem "119607".
- Q347613 unii "2919279".
- Q347613 type ChemicalSubstance.
- Q347613 type Drug.
- Q347613 type ChemicalObject.
- Q347613 type Thing.
- Q347613 type Q8386.
- Q347613 comment "Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a cyclooxygenase-2 selective inhibitor.Valdecoxib was manufactured and marketed under the brand name Bextra by G. D. Searle & Company as an anti-inflammatory arthritis drug. It was approved by the United States Food and Drug Administration on November 20, 2001, to treat arthritis and menstrual cramps.".
- Q347613 label "Valdecoxib".
- Q347613 depiction Valdecoxib.svg.